Showing 4671-4680 of 23276 results for "".
Beyond IOP: Integrating Ocular Surface Resilience Into Glaucoma Management
https://reachmd.com/programs/cme/beyond-iop-integrating-ocular-surface-resilience-into-glaucoma-management/49097/Our experts discuss management strategies for individualized ocular surface rehabilitation while maintaining optimal IOP control in patients with glaucoma.The Current State of Brazilian Butt Lifts
https://reachmd.com/ma-issues-index/2022-nov-dec/the-current-state-of-brazilian-butt-lifts/35227/Florida has become the world capital for BBLs. As mortality rates from the procedure raise concern, the Florida Board of Medicine aims to find ways to ensure safety.Help Protect Your Older Patients This Flu Season: Examining Real-World Data
https://reachmd.com/programs/medical-industry-feature/help-protect-your-older-patients-this-flu-season-examining-real-world-data/26660/Dive into data comparing adjuvanted trivalent influenza and high dose trivalent influenza vaccines in preventing test-confirmed flu hospitalizations among older adults.From Infusion to Injection: Can Subcutaneous Delivery Match Intravenous Standards in Oncology?
https://reachmd.com/programs/project-oncology/from-infusion-to-injection-can-subcutaneous-delivery-match-intravenous-standards-in-oncology/36400/The Future Is Biochemical
https://reachmd.com/topics/practice-development/the-future-is-biochemical/35417/This frontier is being shaped by a category I call “biochemical cues”: modalities like exosomes, peptides, growth factors, PDRN (polydeoxyribonucleotide), and other regenerative approaches, which tap into the body’s own healing and repair mechanisms to deliver profound results.New Pathways in the Treatment of DMD
https://reachmd.com/programs/cme/new-pathways-in-the-treatment-of-dmd/48924/The Duchenne muscular dystrophy (DMD) treatment landscape continues to evolve, with promising therapies emerging from new insights into disease biology. This activity explores the role of aberrant histone deacetylase (HDAC) activity in DMD pathophysiology, including its impact on inflammation, musclEpilepsy Essentials: The Current and Future Landscape of Tuberous Sclerosis Complex Diagnosis and Treatment
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-the-current-and-future-landscape-of-tuberous-sclerosis-complex-diagnosis-and-treatment/32157/Prenatal diagnosis, genetic testing, and mTOR inhibitors have fundamentally transformed the treatment of tuberous sclerosis complex in the neurology clinic.The Future of Oral SERDs: Combination Strategies
https://reachmd.com/programs/cme/the-future-of-oral-serds-combination-strategies/39801/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Routes Reconsidered: A Case-Based Debate in SERD Selection
https://reachmd.com/programs/cme/routes-reconsidered-a-case-based-debate-in-serd-selection/39807/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.From Data to Debate: Global Perspectives on HR+/HER2- mBC Care
https://reachmd.com/programs/cme/from-data-to-debate-global-perspectives-on-hrher2-mbc-care/37268/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.